United States Biotechnology & Medical Research

Soligenix Inc (SNGX)

Track

Track

Ticker: SNGX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Soligenix Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT Executive Director
Transaction date
Purchase
Price
93.20
Quantity 11,471 -46.5%
Value US$4,174,926
3.5
SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT Executive Director
Transaction date
Purchase
Price
458.53
Quantity 17,494 -27.1%
Value US$857,317
3.3
Straube Richard SENIOR VICE PRESIDENT AND CMO Officer
Transaction date
Purchase
Price
54.49
Quantity 57,501 -37.0%
Value US$4,829,476
3.5
SCHABER CHRISTOPHER J CHAIRMAN, CEO AND PRESIDENT Executive Director
Transaction date
Purchase
Price
0.74
Quantity 7,000 +11.1%
Value US$5,179
1.7
Guarino Jonathan L. Senior Vice President and CFO Officer
Transaction date
Purchase
Price
0.70
Quantity 1,000 +10.0%
Value US$700
1.7
Guarino Jonathan L. Senior Vice President and CFO Officer
Transaction date
Purchase
Price
0.71
Quantity 10,000 +inf%
Value US$7,119
3.5
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
0.73
Quantity 10,000 +18.8%
Value US$7,269
3.1
ZELDIS JEROME B Non-Executive Director
Transaction date
Sale
Price
0.90
Quantity 3,000 -11.6%
Value US$2,701
3.1
ZELDIS JEROME B Non-Executive Director
Transaction date
Purchase
Price
0.89
Quantity 3,000 +13.1%
Value US$2,664
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
0.93
Quantity 10,770 +25.4%
Value US$10,016
ZELDIS JEROME B Non-Executive Director
Transaction date
Purchase
Price
0.93
Quantity 2,000 +9.6%
Value US$1,850
3.1
Parks Diane L.
Transaction date
Purchase
Price
0.93
Quantity 14,940 +inf%
Value US$13,870
3.1
ZELDIS JEROME B
Transaction date
Purchase
Price
0.94
Quantity 4,000 +23.6%
Value US$3,740
3.1
ZELDIS JEROME B
Transaction date
Purchase
Price
0.73
Quantity 10,000 +144.6%
Value US$7,274
3.5
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
0.72
Quantity 5,000 +13.4%
Value US$3,577
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
1.17
Quantity 8,700 +30.4%
Value US$10,177
Pearson Mark E. Non-Executive Director
Transaction date
Purchase
Price
1.16
Quantity 170,000 +7.3%
Value US$197,200
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
1.42
Quantity 3,530 +14.1%
Value US$5,012
Essetifin SPA
Transaction date
Purchase
Price
2.12
Quantity 16,416 +5.9%
Value US$34,802
Essetifin SPA
Transaction date
Sale
Price
2.12
Quantity 16,416 -100.0%
Value US$34,802
Essetifin SPA
Transaction date
Purchase
Price
2.12
Quantity 5,954 +2.2%
Value US$12,622
Essetifin SPA
Transaction date
Sale
Price
2.12
Quantity 5,954 -100.0%
Value US$12,622
Essetifin SPA
Transaction date
Purchase
Price
2.12
Quantity 271,140 +inf%
Value US$574,817
Essetifin SPA
Transaction date
Sale
Price
2.12
Quantity 271,140 -100.0%
Value US$574,817
KIRK RANDAL J Large shareholder
Transaction date
Sale
Price
2.54
Quantity 1,881 -2.2%
Value US$4,778
KIRK RANDAL J Large shareholder
Transaction date
Sale
Price
2.54
Quantity 9,695 -2.2%
Value US$24,625
KIRK RANDAL J Large shareholder
Transaction date
Sale
Price
2.70
Quantity 13,893 -13.7%
Value US$37,511
KIRK RANDAL J Large shareholder
Transaction date
Sale
Price
2.70
Quantity 71,607 -13.7%
Value US$193,339
KIRK RANDAL J Large shareholder
Transaction date
Sale
Price
2.97
Quantity 2,278 -2.2%
Value US$6,766
KIRK RANDAL J Large shareholder
Transaction date
Sale
Price
2.97
Quantity 11,739 -2.2%
Value US$34,865
KIRK RANDAL J Large shareholder
Transaction date
Sale
Price
4.01
Quantity 49,875 -8.5%
Value US$199,999
Brughera Marco Maria Non-Executive Director
Transaction date
Purchase
Price
3.16
Quantity 2,000 +266.7%
Value US$6,320
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
3.16
Quantity 15,804 +170.1%
Value US$49,939
RUBIN ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
3.16
Quantity 3,165 +259.4%
Value US$10,001
ZELDIS JEROME B Non-Executive Director
Transaction date
Purchase
Price
1.27
Quantity 2,500 +3.8%
Value US$3,175
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
1.29
Quantity 10,000 +13.2%
Value US$12,878
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
1.21
Quantity 8,265 +12.2%
Value US$10,001
Warusz Joseph Michael VP of Finance/Acting CFO Officer
Transaction date
Purchase
Price
1.21
Quantity 8,265 +176.2%
Value US$10,001
SCHABER CHRISTOPHER J Chairman, CEO and President Executive Director
Transaction date
Purchase
Price
1.05
Quantity 9,523 +19.0%
Value US$9,999
ZELDIS JEROME B Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 23,809 +95.2%
Value US$24,999
Brownlie Keith L Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 19,047 +inf%
Value US$19,999
SCHABER CHRISTOPHER J Chairman CEO and President Executive Director
Transaction date
Purchase
Price
0.51
Quantity 9,900 +24.6%
Value US$5,047
BAM Management LLC Large shareholder
Transaction date
Sale
Price
0.24
Quantity 192,314 -0.9%
Value US$46,155
RUBIN ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
0.21
Quantity 243,902 +inf%
Value US$50,000
LAPOINTE ANTHONY GREGG Non-Executive Director
Transaction date
Purchase
Price
0.21
Quantity 975,610 +inf%
Value US$200,000
CAVAZZA PAOLO Large shareholder
Transaction date
Purchase
Price
0.21
Quantity 2,926,829 +821.9%
Value US$600,000
CAVAZZA PAOLO Large shareholder
Transaction date
Purchase
Price
0.21
Quantity 8,608,580 +18.9%
Value US$1,764,759
SIGMA TAU FINANZIARIA SPA Large shareholder
Transaction date
Purchase
Price
0.21
Quantity 8,608,580 +18.9%
Value US$1,764,759
CAVAZZA CLAUDIO Large shareholder
Transaction date
Purchase
Price
0.21
Quantity 8,608,580 +18.9%
Value US$1,764,759
SCHABER CHRISTOPHER J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.25
Quantity 79,051 +20.1%
Value US$20,000
SIGMA TAU FINANZIARIA SPA Large shareholder
Transaction date
Purchase
Price
0.25
Quantity 3,952,569 +9.5%
Value US$1,000,000
CAVAZZA PAOLO Large shareholder
Transaction date
Purchase
Price
0.25
Quantity 3,952,569 +9.5%
Value US$1,000,000
CAVAZZA CLAUDIO Large shareholder
Transaction date
Purchase
Price
0.25
Quantity 3,952,569 +9.5%
Value US$1,000,000
Biotex Pharma Investments, LLC Large shareholder
Transaction date
Sale
Price
0.20
Quantity 500,000 -2.6%
Value US$100,000
Biotex Pharma Investments, LLC Large shareholder
Transaction date
Sale
Price
0.20
Quantity 500,000 -2.5%
Value US$102,450
CAVAZZA CLAUDIO Large shareholder
Transaction date
Purchase
Price
0.18
Quantity 25,000,000 +150.0%
Value US$4,500,000
SIGMA TAU FINANZIARIA SPA Large shareholder
Transaction date
Purchase
Price
0.18
Quantity 25,000,000 +150.0%
Value US$4,500,000
CAVAZZA PAOLO Large shareholder
Transaction date
Purchase
Price
0.18
Quantity 25,000,000 +150.0%
Value US$4,500,000
MYRIANTHOPOULOS EVAN Chief Financial Officer Executive Director
Transaction date
Purchase
Price
0.31
Quantity 70,000 +45.2%
Value US$21,672
SCHABER CHRISTOPHER J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.29
Quantity 100,000 +34.2%
Value US$29,060
Clavijo James Controller/Treasurer Officer
Transaction date
Purchase
Price
0.30
Quantity 35,000 +65.8%
Value US$10,325
SCHABER CHRISTOPHER J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.47
Quantity 212,766 +266.0%
Value US$100,000
KANZER STEVE H Non-Executive Director
Transaction date
Purchase
Price
0.47
Quantity 212,766 +19.9%
Value US$100,000
Clavijo James Controller/Treasurer Officer
Transaction date
Purchase
Price
0.47
Quantity 53,191 +inf%
Value US$25,000
MYRIANTHOPOULOS EVAN Chief Financial Officer Executive Director
Transaction date
Purchase
Price
0.47
Quantity 53,191 +52.3%
Value US$25,000
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.01
Quantity 875,300 -84.3%
Value US$884,053
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 248,700 -19.3%
Value US$253,674
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.03
Quantity 68,200 -5.0%
Value US$70,246
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.04
Quantity 51,300 -3.6%
Value US$53,352
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.06
Quantity 12,600 -0.9%
Value US$13,356
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.07
Quantity 33,200 -2.3%
Value US$35,524
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.08
Quantity 17,000 -1.2%
Value US$18,360
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.01
Quantity 180,700 -11.0%
Value US$182,507
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 5,600 -0.3%
Value US$5,712
ELAN CORP PLC Large shareholder
Transaction date
Sale
Price
1.05
Quantity 69,200 -4.0%
Value US$72,660
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-03 2025-10-02 B Purchase
3.5
SCHABER CHRISTOPHER J

CHAIRMAN, CEO AND PRESIDENT

Executive Director
11,471 -46.5%
93.20
US$4,174,926 		11,471 -46.5% 93.20 US$4,174,926
2022-05-18 2022-05-18 B Purchase
3.5
SCHABER CHRISTOPHER J

CHAIRMAN, CEO AND PRESIDENT

Executive Director
17,494 -27.1%
458.53
US$857,317 		17,494 -27.1% 458.53 US$857,317
2022-05-18 2022-05-18 B Purchase
3.3
Straube Richard

SENIOR VICE PRESIDENT AND CMO

Officer
57,501 -37.0%
54.49
US$4,829,476 		57,501 -37.0% 54.49 US$4,829,476
2021-12-20 2021-12-17 B Purchase
3.5
SCHABER CHRISTOPHER J

CHAIRMAN, CEO AND PRESIDENT

Executive Director
7,000 +11.1%
0.74
US$5,179 		7,000 +11.1% 0.74 US$5,179
2021-12-15 2021-12-15 B Purchase
1.7
Guarino Jonathan L.

Senior Vice President and CFO

Officer
1,000 +10.0%
0.70
US$700 		1,000 +10.0% 0.70 US$700
2021-12-15 2021-12-14 B Purchase
1.7
Guarino Jonathan L.

Senior Vice President and CFO

Officer
10,000 +inf%
0.71
US$7,119 		10,000 +inf% 0.71 US$7,119
2021-12-14 2021-12-14 B Purchase
3.5
SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
10,000 +18.8%
0.73
US$7,269 		10,000 +18.8% 0.73 US$7,269
2021-05-18 2021-05-14 S Sale
3.1
ZELDIS JEROME B
Non-Executive Director
3,000 -11.6%
0.90
US$2,701 		3,000 -11.6% 0.90 US$2,701
2021-05-18 2021-05-14 B Purchase
3.1
ZELDIS JEROME B
Non-Executive Director
3,000 +13.1%
0.89
US$2,664 		3,000 +13.1% 0.89 US$2,664
2019-11-19 2019-11-19 B Purchase SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
10,770 +25.4%
0.93
US$10,016 		10,770 +25.4% 0.93 US$10,016
2019-11-19 2019-11-19 B Purchase ZELDIS JEROME B Non-Executive Director
2,000 +9.6%
0.93
US$1,850 		2,000 +9.6% 0.93 US$1,850
2019-09-23 2019-09-23 B Purchase
3.1
Parks Diane L.
14,940 +inf%
0.93
US$13,870 		14,940 +inf% 0.93 US$13,870
2019-09-23 2019-09-19 B Purchase
3.1
ZELDIS JEROME B
4,000 +23.6%
0.94
US$3,740 		4,000 +23.6% 0.94 US$3,740
2019-04-22 2019-04-22 B Purchase
3.1
ZELDIS JEROME B
10,000 +144.6%
0.73
US$7,274 		10,000 +144.6% 0.73 US$7,274
2019-04-22 2019-04-22 B Purchase
3.5
SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
5,000 +13.4%
0.72
US$3,577 		5,000 +13.4% 0.72 US$3,577
2018-10-18 2018-10-18 B Purchase SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
8,700 +30.4%
1.17
US$10,177 		8,700 +30.4% 1.17 US$10,177
2018-10-17 2018-10-17 B Purchase Pearson Mark E. Non-Executive Director
170,000 +7.3%
1.16
US$197,200 		170,000 +7.3% 1.16 US$197,200
2018-08-22 2018-08-22 B Purchase SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
3,530 +14.1%
1.42
US$5,012 		3,530 +14.1% 1.42 US$5,012
2017-12-01 2017-11-29 B Purchase Essetifin SPA
16,416 +5.9%
2.12
US$34,802 		16,416 +5.9% 2.12 US$34,802
2017-12-01 2017-11-29 S Sale Essetifin SPA
16,416 -100.0%
2.12
US$34,802 		16,416 -100.0% 2.12 US$34,802
2017-12-01 2017-11-29 B Purchase Essetifin SPA
5,954 +2.2%
2.12
US$12,622 		5,954 +2.2% 2.12 US$12,622
2017-12-01 2017-11-29 S Sale Essetifin SPA
5,954 -100.0%
2.12
US$12,622 		5,954 -100.0% 2.12 US$12,622
2017-12-01 2017-11-29 B Purchase Essetifin SPA
271,140 +inf%
2.12
US$574,817 		271,140 +inf% 2.12 US$574,817
2017-12-01 2017-11-29 S Sale Essetifin SPA
271,140 -100.0%
2.12
US$574,817 		271,140 -100.0% 2.12 US$574,817
2017-05-08 2017-05-08 S Sale KIRK RANDAL J Large shareholder
1,881 -2.2%
2.54
US$4,778 		1,881 -2.2% 2.54 US$4,778
2017-05-08 2017-05-08 S Sale KIRK RANDAL J Large shareholder
9,695 -2.2%
2.54
US$24,625 		9,695 -2.2% 2.54 US$24,625
2017-05-08 2017-05-05 S Sale KIRK RANDAL J Large shareholder
13,893 -13.7%
2.70
US$37,511 		13,893 -13.7% 2.70 US$37,511
2017-05-08 2017-05-05 S Sale KIRK RANDAL J Large shareholder
71,607 -13.7%
2.70
US$193,339 		71,607 -13.7% 2.70 US$193,339
2017-05-08 2017-05-04 S Sale KIRK RANDAL J Large shareholder
2,278 -2.2%
2.97
US$6,766 		2,278 -2.2% 2.97 US$6,766
2017-05-08 2017-05-04 S Sale KIRK RANDAL J Large shareholder
11,739 -2.2%
2.97
US$34,865 		11,739 -2.2% 2.97 US$34,865
2017-05-08 2017-05-04 S Sale KIRK RANDAL J Large shareholder
49,875 -8.5%
4.01
US$199,999 		49,875 -8.5% 4.01 US$199,999
2016-12-20 2016-12-16 B Purchase Brughera Marco Maria Non-Executive Director
2,000 +266.7%
3.16
US$6,320 		2,000 +266.7% 3.16 US$6,320
2016-12-20 2016-12-16 B Purchase SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
15,804 +170.1%
3.16
US$49,939 		15,804 +170.1% 3.16 US$49,939
2016-12-20 2016-12-16 B Purchase RUBIN ROBERT J. Non-Executive Director
3,165 +259.4%
3.16
US$10,001 		3,165 +259.4% 3.16 US$10,001
2015-12-23 2015-12-23 B Purchase ZELDIS JEROME B Non-Executive Director
2,500 +3.8%
1.27
US$3,175 		2,500 +3.8% 1.27 US$3,175
2015-12-23 2015-12-22 B Purchase SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
10,000 +13.2%
1.29
US$12,878 		10,000 +13.2% 1.29 US$12,878
2014-12-24 2014-12-22 B Purchase SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
8,265 +12.2%
1.21
US$10,001 		8,265 +12.2% 1.21 US$10,001
2014-12-24 2014-12-22 B Purchase Warusz Joseph Michael

VP of Finance/Acting CFO

Officer
8,265 +176.2%
1.21
US$10,001 		8,265 +176.2% 1.21 US$10,001
2013-06-26 2013-06-25 B Purchase SCHABER CHRISTOPHER J

Chairman, CEO and President

Executive Director
9,523 +19.0%
1.05
US$9,999 		9,523 +19.0% 1.05 US$9,999
2013-06-26 2013-06-25 B Purchase ZELDIS JEROME B Non-Executive Director
23,809 +95.2%
1.05
US$24,999 		23,809 +95.2% 1.05 US$24,999
2013-06-26 2013-06-25 B Purchase Brownlie Keith L Non-Executive Director
19,047 +inf%
1.05
US$19,999 		19,047 +inf% 1.05 US$19,999
2012-04-11 2012-04-10 B Purchase SCHABER CHRISTOPHER J

Chairman CEO and President

Executive Director
9,900 +24.6%
0.51
US$5,047 		9,900 +24.6% 0.51 US$5,047
2010-08-20 2010-08-18 S Sale BAM Management LLC Large shareholder
192,314 -0.9%
0.24
US$46,155 		192,314 -0.9% 0.24 US$46,155
2010-06-22 2010-06-18 B Purchase RUBIN ROBERT J. Non-Executive Director
243,902 +inf%
0.21
US$50,000 		243,902 +inf% 0.21 US$50,000
2010-06-22 2010-06-18 B Purchase LAPOINTE ANTHONY GREGG Non-Executive Director
975,610 +inf%
0.21
US$200,000 		975,610 +inf% 0.21 US$200,000
2010-06-21 2010-06-18 B Purchase CAVAZZA PAOLO Large shareholder
2,926,829 +821.9%
0.21
US$600,000 		2,926,829 +821.9% 0.21 US$600,000
2010-06-21 2010-06-18 B Purchase CAVAZZA PAOLO Large shareholder
8,608,580 +18.9%
0.21
US$1,764,759 		8,608,580 +18.9% 0.21 US$1,764,759
2010-06-21 2010-06-18 B Purchase SIGMA TAU FINANZIARIA SPA Large shareholder
8,608,580 +18.9%
0.21
US$1,764,759 		8,608,580 +18.9% 0.21 US$1,764,759
2010-06-21 2010-06-18 B Purchase CAVAZZA CLAUDIO Large shareholder
8,608,580 +18.9%
0.21
US$1,764,759 		8,608,580 +18.9% 0.21 US$1,764,759
2009-09-30 2009-09-28 B Purchase SCHABER CHRISTOPHER J

Chief Executive Officer

Executive Director
79,051 +20.1%
0.25
US$20,000 		79,051 +20.1% 0.25 US$20,000
2009-09-28 2009-09-24 B Purchase SIGMA TAU FINANZIARIA SPA Large shareholder
3,952,569 +9.5%
0.25
US$1,000,000 		3,952,569 +9.5% 0.25 US$1,000,000
2009-09-28 2009-09-24 B Purchase CAVAZZA PAOLO Large shareholder
3,952,569 +9.5%
0.25
US$1,000,000 		3,952,569 +9.5% 0.25 US$1,000,000
2009-09-28 2009-09-24 B Purchase CAVAZZA CLAUDIO Large shareholder
3,952,569 +9.5%
0.25
US$1,000,000 		3,952,569 +9.5% 0.25 US$1,000,000
2009-08-11 2009-08-11 S Sale Biotex Pharma Investments, LLC Large shareholder
500,000 -2.6%
0.20
US$100,000 		500,000 -2.6% 0.20 US$100,000
2009-08-11 2009-07-30 S Sale Biotex Pharma Investments, LLC Large shareholder
500,000 -2.5%
0.20
US$102,450 		500,000 -2.5% 0.20 US$102,450
2009-02-13 2009-02-11 B Purchase CAVAZZA CLAUDIO Large shareholder
25,000,000 +150.0%
0.18
US$4,500,000 		25,000,000 +150.0% 0.18 US$4,500,000
2009-02-13 2009-02-11 B Purchase SIGMA TAU FINANZIARIA SPA Large shareholder
25,000,000 +150.0%
0.18
US$4,500,000 		25,000,000 +150.0% 0.18 US$4,500,000
2009-02-13 2009-02-11 B Purchase CAVAZZA PAOLO Large shareholder
25,000,000 +150.0%
0.18
US$4,500,000 		25,000,000 +150.0% 0.18 US$4,500,000
2007-08-29 2007-08-29 B Purchase MYRIANTHOPOULOS EVAN

Chief Financial Officer

Executive Director
70,000 +45.2%
0.31
US$21,672 		70,000 +45.2% 0.31 US$21,672
2007-08-29 2007-08-28 B Purchase SCHABER CHRISTOPHER J

Chief Executive Officer

Executive Director
100,000 +34.2%
0.29
US$29,060 		100,000 +34.2% 0.29 US$29,060
2007-08-29 2007-08-28 B Purchase Clavijo James

Controller/Treasurer

Officer
35,000 +65.8%
0.30
US$10,325 		35,000 +65.8% 0.30 US$10,325
2007-02-13 2007-02-09 B Purchase SCHABER CHRISTOPHER J

Chief Executive Officer

Executive Director
212,766 +266.0%
0.47
US$100,000 		212,766 +266.0% 0.47 US$100,000
2007-02-13 2007-02-09 B Purchase KANZER STEVE H Non-Executive Director
212,766 +19.9%
0.47
US$100,000 		212,766 +19.9% 0.47 US$100,000
2007-02-13 2007-02-09 B Purchase Clavijo James

Controller/Treasurer

Officer
53,191 +inf%
0.47
US$25,000 		53,191 +inf% 0.47 US$25,000
2007-02-13 2007-02-09 B Purchase MYRIANTHOPOULOS EVAN

Chief Financial Officer

Executive Director
53,191 +52.3%
0.47
US$25,000 		53,191 +52.3% 0.47 US$25,000
2004-02-18 2004-02-13 S Sale ELAN CORP PLC Large shareholder
875,300 -84.3%
1.01
US$884,053 		875,300 -84.3% 1.01 US$884,053
2004-02-18 2004-02-13 S Sale ELAN CORP PLC Large shareholder
248,700 -19.3%
1.02
US$253,674 		248,700 -19.3% 1.02 US$253,674
2004-02-18 2004-02-13 S Sale ELAN CORP PLC Large shareholder
68,200 -5.0%
1.03
US$70,246 		68,200 -5.0% 1.03 US$70,246
2004-02-18 2004-02-13 S Sale ELAN CORP PLC Large shareholder
51,300 -3.6%
1.04
US$53,352 		51,300 -3.6% 1.04 US$53,352
2004-02-18 2004-02-13 S Sale ELAN CORP PLC Large shareholder
12,600 -0.9%
1.06
US$13,356 		12,600 -0.9% 1.06 US$13,356
2004-02-18 2004-02-13 S Sale ELAN CORP PLC Large shareholder
33,200 -2.3%
1.07
US$35,524 		33,200 -2.3% 1.07 US$35,524
2004-02-18 2004-02-13 S Sale ELAN CORP PLC Large shareholder
17,000 -1.2%
1.08
US$18,360 		17,000 -1.2% 1.08 US$18,360
2004-02-13 2004-02-12 S Sale ELAN CORP PLC Large shareholder
180,700 -11.0%
1.01
US$182,507 		180,700 -11.0% 1.01 US$182,507
2004-02-13 2004-02-12 S Sale ELAN CORP PLC Large shareholder
5,600 -0.3%
1.02
US$5,712 		5,600 -0.3% 1.02 US$5,712
2004-02-13 2004-02-12 S Sale ELAN CORP PLC Large shareholder
69,200 -4.0%
1.05
US$72,660 		69,200 -4.0% 1.05 US$72,660
Explore more

More insider trading research around Soligenix Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America